Jove
Visualize
Contact Us

Related Concept Videos

Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

7.4K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
7.4K
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

2.2K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.2K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.6K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.6K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

8.5K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
8.5K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.7K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intersecting Roles of Estrogens and Neutrophils in Modulating Innate Immunity in Cancer.

Biomolecules·2026
Same author

Islet-intrinsic sex differences in inflammatory signaling contribute to autoimmune diabetes susceptibility.

bioRxiv : the preprint server for biology·2025
Same author

From Fundamentals to the Clinic: Advancing Obesity Research in Endocrinology.

Journal of the Endocrine Society·2024
Same author

Glycoprotein non-metastatic melanoma protein B promotes tumor growth and is a biomarker for lymphangioleiomyomatosis.

Endocrine-related cancer·2024
Same author

Lymphangioleiomyomatosis: where endocrinology, immunology and tumor biology meet.

Endocrine-related cancer·2023
Same author

Estradiol Augments Tumor-Induced Neutrophil Production to Promote Tumor Cell Actions in Lymphangioleiomyomatosis Models.

Endocrinology·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 22, 2026

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
13:35

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

14.1K

Recent insights on circulating catecholamines in hypertension.

Quang V Ton1, Stephen R Hammes

  • 1Division of Endocrinology, Diabetes, and Metabolism, University of Rochester School of Medicine and Dentistry, 601 Elmwood Ave, Rochester, NY, USA, quang_ton@urmc.rochester.edu.

Current Hypertension Reports
|October 12, 2014
PubMed
Summary

Pheochromocytomas cause high blood pressure by secreting excess catecholamines. New research shows blood vessels also produce catecholamines, offering new hypertension treatment targets.

More Related Videos

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K
Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

21.8K

Related Experiment Videos

Last Updated: Apr 22, 2026

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites
13:35

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

14.1K
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.3K
Assessing Murine Resistance Artery Function Using Pressure Myography
07:25

Assessing Murine Resistance Artery Function Using Pressure Myography

Published on: June 7, 2013

21.8K

Area of Science:

  • Endocrinology
  • Vascular Biology
  • Hypertension Research

Background:

  • Pheochromocytomas, neuroendocrine tumors, elevate blood pressure via excess catecholamine secretion.
  • Catecholamines contribute to endothelial dysfunction, indicated by elevated ADMA and sVCAM-1.
  • Vascular endothelial cells can synthesize and secrete catecholamines, potentially contributing to hypertension.

Purpose of the Study:

  • To explore the role of local catecholamine synthesis in vascular endothelial cells in hypertension.
  • To investigate the link between hypoxia and catecholamine production in the vasculature.
  • To identify novel therapeutic strategies targeting catecholamine pathways for hypertension treatment.

Main Methods:

  • Review of existing literature on pheochromocytomas, catecholamines, and endothelial dysfunction.
  • Analysis of studies demonstrating catecholamine synthesis in vascular endothelial cells.
  • Examination of research on hypoxia-inducible factors and catecholamine-synthesizing enzymes.
  • Overview of emerging therapeutic approaches, including catestatin analogs and renalase enhancers.

Main Results:

  • Pheochromocytomas are a known cause of hypertension due to excess catecholamines.
  • Vascular endothelial cells synthesize catecholamines, particularly under hypoxic conditions.
  • Hypoxia stabilizes hypoxic-inducible factors, upregulating catecholamine-synthesizing enzymes in blood vessels.
  • Elevated ADMA and sVCAM-1 are markers of endothelial dysfunction in pheochromocytoma patients.

Conclusions:

  • Local catecholamine production by vascular endothelial cells, triggered by hypoxia, is a significant factor in hypertension.
  • Understanding this mechanism opens new avenues for treating hypertension.
  • Novel therapies targeting catecholamine pathways, such as catestatin mimics and renalase enhancers, show promise.